Events

Boston, MA – Apr 29 – May 3, 2017 - AATS Centennial Booth 834
Read More

Leipzig, Germany – Feb 11 – 14, 2017 - Heart Medicine 2017
Read More

Press Releases

Austin, TX – March 22, 2017 - HAART 300 Aortic Annuloplasty Device Receives FDA clearance
Read More

Austin, TX – Oct 11, 2016 - BioStable Science & Engineering Completes Direct De Novo Application to FDA for the HAART 300 Aortic Annuloplasty Device Read More

Austin, TX – May 16, 2016 - BioStable Science & Engineering Initiates European Commercialization of the HAART 300 Aortic Annuloplasty Device Read More

Austin, TX – March 8, 2016 - HAART 300 Receives CE Mark Approval
Read More

News and Events

/Admin@bio

About Admin@bio

This author has not yet filled in any details.
So far Admin@bio has created 8 blog entries.

Boston, MA – April 29 – May 3, 2017 – AATS Centennial

AATS Centennial - 100th Anniversary of the American Association for Thoracic Surgery Visit our booth no. 834 at AATS Centennial 2017 from April 29 - May 3, 2017 in Boston, MA.   About BioStable Science & Engineering BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies [...]

March 22nd, 2017|Events, News|

HAART 300 Receives FDA Clearance

BioStable Science & Engineering announces FDA clearance of the HAART™ 300 Aortic Annuloplasty Device Austin, TX – March 22, 2017 - BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device designed for aortic valve repair. BioStable expects [...]

March 22nd, 2017|News, Press Release|

Leipzig, Germany – Feb 11-14, 2017 – Heart Medicine 2017

46th Annual Meeting of the German Society for Thoracic, Cardiac and Vascular Surgery Visit our booth no. C.11 at Heart Medicine 2017 from February 11 – 14, 2017 in Leipzig, Germany.   About BioStable Science & Engineering BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies [...]

January 11th, 2017|Events, News|

Houston, TX – Jan 21-25, 2017 – 53rd STS Annual Meeting

53rd STS Annual Meeting of the Society of Thoracic Surgeons Visit our booth no. 819 at the 53rd STS Annual Meeting from January 21 - 25, 2017 in Houston, TX.   About BioStable Science & Engineering BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that [...]

January 11th, 2017|Events, News|

De Novo Application to FDA for the HAART 300

BioStable Science & Engineering Completes Direct De Novo Application to FDA for the HAART™ 300 Aortic Annuloplasty Device Austin, TX – October 11, 2016 - BioStable Science & Engineering, Inc. announced today that it has completed a direct de novo application to the U.S. Food and Drug Administration (FDA) for Class II designation of the [...]

October 11th, 2016|News, Press Release|

Barcelona, Spain – Oct 1-5, 2016 – 30th EACTS Annual Meeting

European Association for Cardiothoracic Surgery (EACTS) Annual Meeting Visit our booth 88 at the 30th EACTS Annual Meeting from October 1-5, 2016 at the Centre Convencions Internacional de Barcelona (CCIB) in Barcelona, Spain.   About BioStable Science & Engineering BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve [...]

August 24th, 2016|Events, News|

European Commercialization of the HAART 300

BioStable Science & Engineering Initiates European Commercialization of the HAART™ 300 Aortic Annuloplasty Device First commercial implantation performed by Dr. Domenico Mazzitelli, at the German Heart Center Munich Austin, TX – May 16, 2016 - BioStable Science & Engineering, Inc. announced today that the first commercial implantation of its HAART 300 Aortic Annuloplasty Device was [...]

May 16th, 2016|News, Press Release|

HAART 300 Receives CE Mark Approval

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device Patented aortic valve repair technology offers a new alternative to aortic valve replacement Austin, TX – March 8, 2016 - BioStable Science & Engineering, Inc. announced today the company has received CE Mark approval for the HAART 300 Aortic Annuloplasty [...]

March 8th, 2016|News, Press Release|